causal
RNA drug demand is cyclical with biotech funding
Demand for RNA-based drugs is tied to the mRNA theme in pharma, and funding swings cause customers to shift R&D versus commercialization spend, which shows up in the company's results.
causalpending
Speaker
Marc de VosEvidence Quote
“companies focus less on R&D one year and more on commercialization to respond to funding changes.”
Created: 11/12/2026, 11:55:35 AM
Your notes
Loading notes...